Jounce Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for JNCE

Based on 2 analysts offering 12 month price targets for Jounce Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell JNCE stock?

Based on 2 analysts offering ratings for Jounce Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
1 analysts 50%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their JNCE stock forecasts and price targets.

JNCE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Bottom 5%
Strong BuyMaintains$5.00+173.22%2023-01-03
Raymond James
Top 20%

1 of 1

JNCE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JNCE$1.83$4.00+118.58%Strong Buy
EYPT$2.83$32.67+1,054.31%Strong Buy

Jounce Therapeutics Stock Forecast FAQ

Is Jounce Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: JNCE) stock is to Strong Buy JNCE stock.

Out of 2 analysts, 1 (50%) are recommending JNCE as a Strong Buy, 1 (50%) are recommending JNCE as a Buy, 0 (0%) are recommending JNCE as a Hold, 0 (0%) are recommending JNCE as a Sell, and 0 (0%) are recommending JNCE as a Strong Sell.

If you're new to stock investing, here's how to buy Jounce Therapeutics stock.

What is JNCE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year JNCE price target, the average JNCE price target is $4.00, with the highest JNCE stock price forecast at $5.00 and the lowest JNCE stock price forecast at $3.00.

On average, Wall Street analysts predict that Jounce Therapeutics's share price could reach $4.00 by Jan 3, 2024. The average Jounce Therapeutics stock price prediction forecasts a potential upside of 118.58% from the current JNCE share price of $1.83.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.